Get everything you need to know about the Medicamen Organics IPO. Explore Medicamen Organics IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Medicamen Organics Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a broad range of pharmaceutical dosage forms. These include generic tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. Operating primarily as a contract and third-party manufacturer, the company serves both government and private institutions. Medicamen Organics markets its products domestically and internationally through third-party distributors and has begun establishing a direct presence in international markets.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 21 Jun - 25 Jun 2024 |
IPO Price Band | ₹ 32 - 34 per share |
Fresh Issue | Upto 31,00,000 Shares |
Offer For Sale | NIL |
Total IPO Size | Approx ₹ 10.54 crore |
Face Value | ₹ 10 |
Listing On | NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 21 Jun 2024 |
IPO Closing Date | 25 Jun 2024 |
Basis Of Allotment | 26 Jun 2024 |
Refunds | 26 Jun 2024 |
Demat Transfer | 27 Jun 2024 |
IPO Listing Date | 28 Jun 2024 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | 31st March 2024 |
---|---|---|---|---|
Total Income | 25.06 | 21.19 | 22.96 | 25.29 |
Total Expenses | 24.57 | 20.93 | 21.60 | 21.90 |
Net Profit/Loss | 0.30 | 0.10 | 0.97 | 2.40 |
NPM (*) | 1.19 | 0.44 | 4.38 | 9.51 |
Total Assets | 26.34 | 27.54 | 32.59 | 38.58 |
Total Liabilities | 18.88 | 19.53 | 23.61 | 23.40 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹ cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | 31st March 2024 |
---|---|---|---|---|
EPS | 0.50 | 0.17 | 1.62 | 3.18 |
ROE (%) | 0.04 | 0.01 | 0.12 | 14.50 |
ROCE (%) | 5.68 | 4.09 | 9.71 | 19.90 |
D/E Ratio | 1.28 | 1.36 | 1.38 | 1.28 |
Current Ratio | 0.86 | 0.88 | 0.95 | 1.25 |
EBITDA MARGIN (%) | 6.57 | 6.71 | 12.12 | 18.80 |
* Compiled from DRHP/RHP for valuation purposes.
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
Name | Total Income | P/E | EPS | RoNW | NAV |
---|---|---|---|---|---|
Medicamen Organics Limited | 25.29 | 10.69 | 3.18 | 15.83 | 17.66 |
Brooks Laboratories Ltd | 63.41 | 10.60 | -12.57 | -28.26 | 30.10 |
Cian Healthcare Ltd | 68.10 | 53.84 | 0.43 | 1.75 | 22.40 |
Zenotech Laboratories Ltd | 43.51 | 38.76 | 1.90 | 14.08 | 14.20 |
* Revenue in (₹ cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 173.03 |
Non-Institutional Investor (NII) | 1343.83 |
Retail Individual Investor (RII) | 1309.77 |
Total | 993.56 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Medicamen Organics Limited
10 Community Centre No 2 Ashok Vihar Phase II, New Delhi, Delhi, 110052, India.
Phone: +91-9818222845
Email: cs@mediorganics.in
Website: www.medicamenorganics.com